Bekanamycin
Chemical compound
From Wikipedia, the free encyclopedia
Bekanamycin (INN; kanamycin B) is an aminoglycoside antibiotic.[1][2] It was discovered in 1957, along with Kanamycin A,[3] though it was not identified and named until the next year, when it was studied independently.[4] It was later found to be nearly identically efficacious as Kanamycin A, with the only limitation being lower efficacy towards Mycobacterium agents.[5] Animal studies also showed that Bekanamycin was more toxic than Kanamycin A.[6]
Legal status
- In general: ℞ (Prescription only)
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| NIAID ChemDB | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.022.881 |
| Chemical and physical data | |
| Formula | C18H37N5O10 |
| Molar mass | 483.519 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |